2021
DOI: 10.1038/s41598-021-99752-5
|View full text |Cite|
|
Sign up to set email alerts
|

Gene.iobio: an interactive web tool for versatile, clinically-driven variant interrogation and prioritization

Abstract: With increasing utilization of comprehensive genomic data to guide clinical care, anticipated to become the standard of care in many clinical settings, the practice of diagnostic medicine is undergoing a notable shift. However, the move from single-gene or panel-based genetic testing to exome and genome sequencing has not been matched by the development of tools to enable diagnosticians to interpret increasingly complex or uncertain genomic findings. Here, we present gene.iobio, a real-time, intuitive and inte… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 39 publications
0
3
0
Order By: Relevance
“…This integration with variant prioritization tools is critical in order to ensure that clin.iobio supports both phenotype-and gene-based approaches, as well as variants in genes not previously associated with the patient's phenotypes. This variant review step is powered by our previously published gene.iobio [12] tool, whereby variants in all provided genes are annotated with a comprehensive set of annotations, including ClinVar [13], gnomAD [14], and REVEL [15] for missense variants. This variant prioritization step also provides OMIM-associated [16] genetic disorders and PubMed publications associated with the selected gene.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…This integration with variant prioritization tools is critical in order to ensure that clin.iobio supports both phenotype-and gene-based approaches, as well as variants in genes not previously associated with the patient's phenotypes. This variant review step is powered by our previously published gene.iobio [12] tool, whereby variants in all provided genes are annotated with a comprehensive set of annotations, including ClinVar [13], gnomAD [14], and REVEL [15] for missense variants. This variant prioritization step also provides OMIM-associated [16] genetic disorders and PubMed publications associated with the selected gene.…”
Section: Resultsmentioning
confidence: 99%
“…Clin.iobio utilizes and coordinates multiple components and tools within the iobio suite of visual web-based genomics tools. These include tools for reviewing data quality metrics (based on bam.iobio [22] and vcf.iobio), generating lists of genes associated with specific phenotypes and genetic disorders (based on genepanel.iobio [21]), and variant prioritization and interpretation (based on gene.iobio [12]). Combining these code bases, clin.iobio passes the outputs from individual steps to subsequent steps, resulting in a complete start-tofinish diagnostic workflow.…”
Section: System Overviewmentioning
confidence: 99%
“…Several existing tools have been developed in the academic sector for reviewing variants in defined gene lists (gene.iobio) (Di Sera et al, 2021) or for broader review and prioritization of variants in genomic analysis (Exomiser, GEMINI, PhenoDB, slivar) (Buske et al, 2013; Paila et al, 2013; P. N. Robinson et al, 2014; Sobreira et al, 2015). This is also an area of development in the commercial arena, with many fee‐based platforms available, such as those listed on ClinGen's Genomic Analysis Software Platforms list (https://clinicalgenome.org/tools/genomic-analysis-software-platform-list/).…”
Section: Introductionmentioning
confidence: 99%